Skip to main content

Roche NimbleGen, BioDiscovery to Team on CGH Analysis Tools

NEW YORK (GenomeWeb News) – Roche said today that its Roche NibleGen subsidiary has inked an alliance with Los Angeles-based BioDiscovery to offer a combination of products targeting comparative genomic hybridization.
 
The pact will combine new high-density, 2.1 million probe arrays from Roche NimbleGen with BioDiscovery’s Nexus Copy Number software foe use in whole-genome CGH analysis. Under the alliance, the firms will co-market and co-promote their products and services to scientists worldwide.
 
In addition, Roche NimbleGen said that the firm would present data generated from the arrays using Nexus software to researchers through a series of seminars.
 
Terms of the alliance were not disclosed.
 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.